Wearable Injectors Market is anticipated to grow up to USD 21.7 billion, at a CAGR of 13.3% during the forecast period 2022-2031

The global wearable injectors market was valued at USD 5.3 billion in 2021 and it is anticipated to grow up to USD 21.7 billion by 2031, at a CAGR of 13.3% during the forecast period.

Drug delivery systems known as wearable injectors attach to the body and automatically administer patients' prescribed doses at the right moment. Wearable injectors, in contrast to insulin pumps, is a one-time use devices that are comfortably worn on the body while the medication is subcutaneously injected over a pre-programmed period of seconds or hours. They are taken out of the body and conveniently disposed after the entire dose has been injected. The concept of patient centricity and a greater emphasis on human factors in drug delivery design have encouraged the development of such devices.

Read more about Wearable Injectors Market here: https://www.globalinsightservices.com/reports/wearable-injectors-market/

Market Trends and Drivers:

A growing emphasis on the use of biologics and monoclonal antibodies (mAbs) to treat diseases such as rheumatoid arthritis, cardiovascular disease, and cancer will provide significant growth opportunities for wearable injectors, as these drugs must be administered parenterally (intravenous, subcutaneous, or intramuscular delivery). According to PhRMA (Pharmaceutical Research and Manufacturers of America), 907 biologics were in development in 2013; the number of biologic drugs in development is continuing to grow exponentially, with over 2,700 remedies in development as of mid-2017, more than tripling the 907 in development in 2013. mAb-based biotherapies account for half of the top 100 drugs and are expected to continue to dominate the pharmaceutical market.

Market Restraints and Challenges:

Wearable injectors are not reimbursed in a number of developing countries. In India, for example, wearable insulin pumps are not reimbursed, and no specific guidelines for their use are provided on prescription. Patients with Type 1 diabetes in China must pay for insulin pumps and supplies out of pocket. The lack of reimbursement has a direct impact on access to and adoption of wearable injectors, and is thus expected to have a negative impact on market growth in the coming years.

To remain 'ahead' of your competitors, request for a sample: https://www.globalinsightservices.com/request-sample/GIS10384/

COVID-19 Impact:

The COVID-19 pandemic's uncertainty has influenced demand for various therapies and wearable drug delivery devices. To prevent the spread of the infection and to keep high-risk patients from becoming infected, healthcare systems around the world delayed treatments for diseases such as cancer. The risks for patients receiving care increased as the pandemic began. During the pandemic, hospitals, where the majority of patients receive treatment, also became high-risk environments. To address these challenges and provide effective care to patients suffering from various diseases, a shift from hospital-based care to home-based care has occurred.

Major Players in the Global Wearable Injectors Market:

The key players in the market are Ypsomed (Switzerland), Amgen (US), Subcuject (Denmark), Enable Injections (US), Medtronic plc (Ireland), Insulet Corporation (US), United Therapeutics Corp. (US), CeQur SA (Switzerland), Sensile Medical (Switzerland), ATS Automation (Canada), West Pharmaceutical Services, Inc. (US), Tandem Diabetes Care (US), Sonceboz (Switzerland), Noble (US), Elcam Drug Delivery Devices (Israel), Bespak Europe Ltd. (UK), Stevanato Group (Italy), Sorrel Medical (Israel), Weibel CDS AG (Switzerland), and Neuma (US) among others.

Get a Customized Scope to Match Your Need Ask an Expert: https://www.globalinsightservices.com/request-customization/GIS10384/

With Global Insight Services, you receive:
- 10-year forecast to help you make strategic decisions
- In-depth segmentation which can be customized as per your requirements
- Free consultation with lead analyst of the report
- Excel data pack included with all report purchases
- Robust and transparent research methodology

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.